Daniel Apel

Daniel Apel

Director of Finance/CFO at ARROWHEAD PHARMACEUTICALS, INC.

Net worth: 14 M $ as of 2026-06-29

Health Technology
Consumer Services
Commercial Services

Profile

Daniel J.
Apel
is currently Director at Conceptus, Inc. since 2013, Director at Biotechnology Innovation Organization, and Chief Financial Officer at Arrowhead Pharmaceuticals, Inc. starting in 2025.
Formerly, Mr. Apel was Chief Financial Officer at Bayer Corp.
from 2016 to 2019 and Global Head-Financial Planning & Analysis at Walgreens Boots Alliance, Inc. from 2019 to 2024.
Education includes undergraduate studies at the University of Pennsylvania and an MBA from the University of California, Berkeley.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-01-05 176,200 ( 0.13% ) 14 M $ 2026-06-29

Daniel Apel active positions

CompaniesPositionStart
ARROWHEAD PHARMACEUTICALS, INC. Director of Finance/CFO 2025-05-12
Director/Board Member -
Director/Board Member 2013-06-04

Former positions of Daniel Apel

CompaniesPositionEnd
WALGREENS BOOTS ALLIANCE, INC. Corporate Officer/Principal 2023-12-31
Director of Finance/CFO 2018-12-31
See the detail of Daniel Apel's experience

Training of Daniel Apel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

68

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Retail Trade